Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: Malignant catatonia is a life-threatening form of catatonia characterized by hyperthermia and autonomic dysfunction along with the motor and behavioral symptoms associated with catatonia. Neuroleptic malignant syndrome (NMS) is considered by some to be an iatrogenic form of malignant catatonia occurring secondary to neuroleptic use. NMS occurs in 0.02% to 3% of patients treated with neuroleptics and is typically a self-limited condition, resolving within 7-14 days of stopping the offending drug.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Please sign in or purchase this PDF for $40.00.